"Who is protected against monkeypox?"
The New York Times interviewed Dr. Anne Rimoin about whether the current monkeypox outbreak is likely to swell into a large epidemic.
For a world weary of fighting the coronavirus, the monkeypox outbreak poses a key question: Am I at risk?
The answer is reassuring. Most children and adults with healthy immune systems are likely to dodge severe illness, experts said in interviews. But there are two high-risk groups.
One comprises infants younger than six months. But they are not yet affected by the current outbreak. And many older adults, the group most likely to succumb to the monkeypox virus, are at least somewhat protected by decades-old smallpox vaccinations, studies suggest.
Faculty Referenced by this Article
Robert J. Kim-Farley, MD, MPH, is a Professor-in-Residence with joint appointments in the Departments of Epidemiology and Community Health Sciences
Dr. Joseph Davey is an infectious disease epidemiologist with over 20 years' experience leading research on HIV/STI services for women and children.
Related Content
Dr. Anne Rimoin as been studying monkeypox for two decades, including as director of the UCLA Center for Global and Immigrant Health and founder/director of the affiliated UCLA-DRC Health Research and Training Program, in the Democratic Republic of the Congo (DRC).
Source: UCLA Newsroom Read Full Article
UCLA FSPH professors of epidemiology, Dr. Anne Rimoin and Dr. Zunyou Wu, to serve on an emergency World Health Organization (WHO) panel as part of the WHO’s response to the current monkeypox outbreak.
Source: World Health Organization Read Full Article